AbCellera Biologics Inc.ABCLNASDAQ
Loading
Year-over-year net income growth rate
5Y CAGR
-54.7%/yr
Long-term compound
Percentile
P78
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 84.34% |
| Q3 2025 | -64.48% |
| Q2 2025 | 23.88% |
| Q1 2025 | -33.36% |
| Q4 2024 | 33.06% |
| Q3 2024 | -38.39% |
| Q2 2024 | 9.06% |
| Q1 2024 | 13.87% |
| Q4 2023 | -64.80% |
| Q3 2023 | 6.28% |
| Q2 2023 | 23.89% |
| Q1 2023 | -34.18% |
| Q4 2022 | -212.28% |
| Q3 2022 | 492.39% |
| Q2 2022 | -104.02% |
| Q1 2022 | 181.20% |
| Q4 2021 | 380.39% |
| Q3 2021 | -820.36% |
| Q2 2021 | -101.98% |
| Q1 2021 | 0.19% |
| Q4 2020 | 4444.58% |
| Q3 2020 | -140.18% |
| Q2 2020 | 420.26% |
| Q1 2020 | -27.55% |
| Q4 2019 | -4652.70% |
| Q3 2019 | 111.90% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |